99 related articles for article (PubMed ID: 9458363)
1. Expression of Tn antigen and N-acetyllactosamine residues in malignant and benign human breast tumors detected by lectins and monoclonal antibody 83D4.
Konska G; Guillot J; De Latour M; Fonck Y
Int J Oncol; 1998 Feb; 12(2):361-7. PubMed ID: 9458363
[TBL] [Abstract][Full Text] [Related]
2. [Expression of T and Tn antigens in breast cancers].
Konska G; Favy D; Guillot J; Bernard-Gallon D; de Latour M; Fonck Y
C R Seances Soc Biol Fil; 1998; 192(4):733-47. PubMed ID: 9842474
[TBL] [Abstract][Full Text] [Related]
3. Expression of c-kit in common benign and malignant breast lesions.
Kondi-Pafiti A; Arkadopoulos N; Gennatas C; Michalaki V; Frangou-Plegmenou M; Chatzipantelis P
Tumori; 2010; 96(6):978-84. PubMed ID: 21388062
[TBL] [Abstract][Full Text] [Related]
4. Study of the expression of Tn antigen in different types of human breast cancer cells using VVA-B4 lectin.
Konska G; Guerry M; Caldefie-Chezet F; De Latour M; Guillot J
Oncol Rep; 2006 Feb; 15(2):305-10. PubMed ID: 16391846
[TBL] [Abstract][Full Text] [Related]
5. Association of N-acetyllactosamine with tumor progression in human breast cancer: a study using a 16 kDa chick embryo lectin.
Henou C; Didier E; De Latour M; Kwiatkowski F; Communal Y; Besse G; Bignon Y
Int J Mol Med; 1998 Apr; 1(4):771-5. PubMed ID: 9852296
[TBL] [Abstract][Full Text] [Related]
6. Armc8 expression was elevated during atypia-to-carcinoma progression and associated with cancer development of breast carcinoma.
Fan C; Zhao Y; Mao X; Miao Y; Lin X; Jiang G; Zhang X; Han Q; Luan L; Wang E
Tumour Biol; 2014 Nov; 35(11):11337-43. PubMed ID: 25119601
[TBL] [Abstract][Full Text] [Related]
7. Purification and characterisation of a breast-cancer-associated glycoprotein not expressed in normal breast and identified by monoclonal antibody 83D4.
Pancino G; Osinaga E; Charpin C; Mistro D; Barque JP; Roseto A
Br J Cancer; 1991 Mar; 63(3):390-8. PubMed ID: 1706194
[TBL] [Abstract][Full Text] [Related]
8. The localization of the insulin-like growth factor receptor 1 (IGFR-1) in benign and malignant breast tissue.
Happerfield LC; Miles DW; Barnes DM; Thomsen LL; Smith P; Hanby A
J Pathol; 1997 Dec; 183(4):412-7. PubMed ID: 9496257
[TBL] [Abstract][Full Text] [Related]
9. p53 protein expression in benign and malignant breast lesions.
Ioakim-Liossi A; Markopoulos C; Karakitsos P; Safioleas M; Gogas J; Vaiopoulos G
Acta Cytol; 1998; 42(4):918-22. PubMed ID: 9684577
[TBL] [Abstract][Full Text] [Related]
10. Localization of mineralocorticoid receptor and 11 beta-hydroxysteroid dehydrogenase type II in human breast and its disorders.
Sasano H; Frost AR; Saitoh R; Matsunaga G; Nagura H; Krozowski ZS; Silverberg SG
Anticancer Res; 1997; 17(3C):2001-7. PubMed ID: 9216657
[TBL] [Abstract][Full Text] [Related]
11. Localization of binding sites of Ulex europaeus I, Helix pomatia and Griffonia simplicifolia I-B4 lectins and analysis of their backbone structures by several glycosidases and poly-N-acetyllactosamine-specific lectins in human breast carcinomas.
Ito N; Imai S; Haga S; Nagaike C; Morimura Y; Hatake K
Histochem Cell Biol; 1996 Sep; 106(3):331-9. PubMed ID: 8897074
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical expression of T, Tn and sialyl-Tn antigens and clinical outcome in human breast carcinoma.
Imai J; Ghazizadeh M; Naito Z; Asano G
Anticancer Res; 2001; 21(2B):1327-34. PubMed ID: 11396208
[TBL] [Abstract][Full Text] [Related]
13. [P21 expression of ras oncogene product in benign and malignant female mammary lesions].
Zhang JZ; Fan SC; Liu HF
Zhonghua Bing Li Xue Za Zhi; 1994 Oct; 23(5):302-3. PubMed ID: 7874767
[TBL] [Abstract][Full Text] [Related]
14. Immunocytological analysis of the Tn associated antigen 83D4 in serous effusions from patients with cancer: comparison with Tn soluble glycoprotein.
Beuzelin-Yvraut M; Bourguignat A; Phillips E; Roseto A; Osinaga E
J Clin Pathol; 1995 May; 48(5):433-7. PubMed ID: 7629290
[TBL] [Abstract][Full Text] [Related]
15. The phosphorylated form of connexin43 is up-regulated in breast hyperplasias and carcinomas and in their neoformed capillaries.
Gould VE; Mosquera JM; Leykauf K; Gattuso P; Dürst M; Alonso A
Hum Pathol; 2005 May; 36(5):536-45. PubMed ID: 15948121
[TBL] [Abstract][Full Text] [Related]
16. Expression of Vicia villosa agglutinin (VVA)-binding glycoprotein in primary breast cancer cells in relation to lymphatic metastasis: is atypical MUC1 bearing Tn antigen a receptor of VVA?
Kawaguchi T; Takazawa H; Imai S; Morimoto J; Watanabe T; Kanno M; Igarashi S
Breast Cancer Res Treat; 2006 Jul; 98(1):31-43. PubMed ID: 16752227
[TBL] [Abstract][Full Text] [Related]
17. A comparison of the patterns of laminin expression in fibroadenoma, fibrocystic diseases, pre-invasive and invasive ductal breast carcinoma.
Zheng WQ; Looi LM; Cheah PL
Pathology; 2001 Aug; 33(3):303-6. PubMed ID: 11523929
[TBL] [Abstract][Full Text] [Related]
18. Expression of hyaluronan in benign and malignant breast lesions.
Auvinen PK; Parkkinen JJ; Johansson RT; Agren UM; Tammi RH; Eskelinen MJ; Kosma VM
Int J Cancer; 1997 Oct; 74(5):477-81. PubMed ID: 9355968
[TBL] [Abstract][Full Text] [Related]
19. P53 expression in patients with malignant and benign breast diseases.
Kalogeraki A; Panayiotides J; Tamiolakis D; Tzardi M; Chaniotis V; Chalkiadakis G; Melissas J; Stiftsis D; Kanavaros P; Delides GS
Anticancer Res; 2000; 20(3A):1801-5. PubMed ID: 10928110
[TBL] [Abstract][Full Text] [Related]
20. Consistent lack of CD34-positive stromal cells in the stroma of malignant breast lesions.
Kuroda N; Jin YL; Hamauzu T; Toi M; Miyazaki E; Hiroi M; Moriki T; Enzan H
Histol Histopathol; 2005 Jul; 20(3):707-12. PubMed ID: 15944918
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
